Status:
COMPLETED
National Survey on Infiltrative Breast Cancer
Lead Sponsor:
AstraZeneca
Conditions:
Infiltrative Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this observational study is to describe radiological, clinical and histological characteristics of women with infiltrative breast cancer.
Eligibility Criteria
Inclusion
- Women\> or = 18 years old
- Women with newly diagnosis of infiltrative breast cancer
- Agree to take part in this study
Exclusion
- Women with other malignant tumor (except in situ cervical carcinoma or treated basal cell carcinoma)
- Women with in situ ductal carcinoma or in situ lobular carcinoma
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00696527
Start Date
June 1 2007
End Date
July 1 2008
Last Update
December 10 2010
Active Locations (107)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aix-en-Provence, France
2
Research Site
Alès, France
3
Research Site
Amilly, France
4
Research Site
Angers, France